USP7 and chronic kidney disease: We further elucidate that CK2 can phosphorylate RUNX2, activate it, and recruit USP7 to mediate deubiquitination, stabilizing RUNX2 expression and improving osteogenesis and bone metabolism in the CKD-MBD model.